DUTCH Test Explained: Comprehensive Hormone Metabolite Testing for Integrative Practice

A practitioner-grade guide to DUTCH test hormone testing — what it measures, how to read oestrogen metabolism pathways, cortisol curves, and melatonin markers, plus ordering in Australia and clinical applications.

This article is intended for health professionals and informed consumers. DUTCH test results require clinical interpretation. This is not medical advice.

What Is the DUTCH Test? An Overview of Dried Urine Hormone Testing

DUTCH test hormone testing — where DUTCH stands for Dried Urine Test for Comprehensive Hormones — is a functional diagnostic tool developed by Precision Analytical (USA) that has become one of the most clinically detailed hormone panels available to naturopaths, integrative GPs, and functional medicine practitioners worldwide, including in Australia.

Unlike a standard blood hormone panel that captures a single snapshot in time, the DUTCH test collects four to five dried urine samples across a full day, typically timed around waking, mid-morning, late afternoon, and bedtime. The dried filter-paper collection method stabilises hormones during shipping to the laboratory, making it practical for patients collecting at home without refrigeration requirements.

The core clinical value of DUTCH test hormone testing is its capacity to measure not just circulating hormones, but their downstream metabolites — the breakdown products that reveal how the body is actually processing and clearing sex hormones and cortisol. This metabolite map is invisible on serum or saliva panels, which is precisely why the DUTCH has earned significant uptake in integrative practice. Practitioners in Australia can now access this panel through authorised distributors, making it a realistic option for clinical ordering without international shipping delays.

What Does the DUTCH Test Measure?

The DUTCH Complete panel covers four major domains, each providing clinically actionable information.

Sex Hormones and Their Metabolites

The DUTCH measures the parent sex hormones — oestrone (E1), oestradiol (E2), oestriol (E3), progesterone, testosterone, and DHEA-S — but its distinguishing feature is the simultaneous measurement of their hepatic and gut-processed metabolites.

For oestrogens, this includes:

2-hydroxyoestrone (2-OH-E1) — the favourable "protective" metabolite associated with lower proliferative activity
4-hydroxyoestrone (4-OH-E1) — a potentially genotoxic metabolite that can form DNA adducts
16-alpha-hydroxyoestrone (16-OH-E1) — a strongly oestrogenic metabolite linked to tissue proliferation

Progesterone metabolites (alpha-pregnanediol, beta-pregnanediol) and androgens (androsterone, etiocholanolone, 5a-DHT, androstanediol) are also quantified, providing a comprehensive androgenic and progestogenic picture that standard panels cannot offer.

Cortisol and Cortisol Metabolites

Cortisol assessment on the DUTCH is multi-layered:

Free cortisol across the diurnal curve (four to five time points)
Free cortisone as a proxy for cortisol clearance and 11-beta-HSD2 enzyme activity
Total cortisol metabolites (THF + allo-THF + THE) — the aggregate output of the adrenal glands, independent of clearance rate
Cortisol awakening response (CAR) — a two-point morning collection (immediately on waking, then 30 minutes post-waking) that reflects HPA axis reactivity and is strongly associated with stress resilience, immune function, and metabolic regulation

This layered cortisol assessment is one of the DUTCH's greatest clinical advantages; a patient can show low free cortisol on a saliva panel yet have elevated cortisol metabolites, pointing to accelerated clearance rather than true adrenal insufficiency — a clinically critical distinction.

Organic Acid Markers

The DUTCH Complete includes a targeted organic acid panel covering:

Melatonin (6-OHMS) — the primary urinary melatonin metabolite, providing a reliable overnight marker of pineal function
Oxidative stress marker (8-OHdG) — a DNA oxidation product reflecting systemic oxidative burden
Vitamin B12 marker (methylmalonic acid) — functional B12 status indicator; elevated MMA is a sensitive marker of intracellular B12 insufficiency and is directly relevant when assessing patients with MTHFR variants and impaired methylation capacity, where functional B12 and B6 status are core intervention targets
B6 marker (xanthurenate) — functional B6 status relevant to oestrogen metabolism and neurotransmitter synthesis
Neurotransmitter metabolites — including homovanillate (HVA, dopamine metabolite) and vanilmandelate (VMA, noradrenaline/adrenaline metabolite)
Glutathione marker (pyroglutamate) — reflecting cellular antioxidant capacity

Androgens and PCOS Markers

Free testosterone, DHEA-S, androstenedione, and the androgenic metabolites 5a-androstanediol and 5b-androstanediol are all measured, allowing assessment of 5-alpha reductase enzyme activity — highly relevant in PCOS, hirsutism, and androgenic alopecia workups.

DUTCH vs Serum vs Saliva: Why Dried Urine Captures What Others Miss

Practitioners frequently encounter the question from patients and colleagues: why choose the DUTCH over a standard blood test or a saliva hormone panel? The answer lies in what each collection method can and cannot measure.

Serum (Blood) Testing

Serum measures total and sometimes free hormone concentrations at a single time point. It is adequate for diagnosing frank pathology — primary hypogonadism, Cushing's disease, Addison's disease — but it does not capture:

Diurnal cortisol patterns
Hormone metabolites or clearance pathways
Oestrogen detoxification efficiency
Overnight melatonin output

Additionally, serum oestradiol is notoriously difficult to interpret on HRT, particularly with transdermal preparations, which can produce supraphysiological serum readings while tissue levels remain clinically appropriate.

Saliva Testing

Salivary hormone panels offer an advantage over serum in one key area: they measure bioavailable (unbound) hormone fractions rather than total hormone, and they can be collected at multiple time points across the day, making salivary cortisol curves a practical clinical tool. However, saliva still cannot measure hormone metabolites, and collection difficulties (volume, medication contamination, blood in saliva) introduce error.

Dried Urine (DUTCH)

Urine captures what the body has already processed and excreted. By measuring the full metabolite cascade alongside free hormone fractions, the DUTCH provides:

Phase I and Phase II liver detoxification efficiency for oestrogens
Aggregate adrenal output over 24 hours (total cortisol metabolites), not just a single-time-point reading
Overnight melatonin without nocturnal blood or saliva collection
Functional nutrient status via organic acids
Stable sample collection — dried urine at room temperature is stable for weeks, eliminating cold-chain concerns

The limitation is that dried urine does not measure LH, FSH, or thyroid markers, so the DUTCH is typically combined with standard serum pathology rather than replacing it entirely.

Reading Oestrogen Metabolism: The 2-OH, 4-OH, and 16-OH Pathways

One of the most clinically significant outputs of DUTCH test hormone testing is the oestrogen metabolite map. Oestrogens undergo Phase I hydroxylation in the liver via cytochrome P450 enzymes, producing three distinct hydroxylated metabolites that carry very different biological activity profiles.

The 2-Hydroxylation Pathway (CYP1A1/CYP1A2)

2-hydroxyoestrone (2-OH-E1) is generally considered the most favourable oestrogen metabolite. It has weak oestrogenic activity, does not stimulate cell proliferation, and is associated in epidemiological studies with a lower risk of oestrogen-sensitive conditions. 2-OH-E1 can be further methylated to 2-methoxyoestrone by COMT (catechol-O-methyltransferase), a Phase II detoxification step that renders the metabolite essentially inactive. COMT function is affected by the COMT Val158Met polymorphism, magnesium cofactor status, and S-adenosylmethionine (SAMe) availability — all modifiable in naturopathic practice. SAMe availability is itself upstream-dependent on the methylation cycle, meaning patients with MTHFR variants and impaired methylation capacity may show consistently poor 2-OH-E1 methylation efficiency on DUTCH reporting even with adequate dietary folate intake.

Nutritional inducers of the 2-OH pathway include indole-3-carbinol (I3C) and its intestinal metabolite diindolylmethane (DIM), found in cruciferous vegetables, as well as resveratrol and omega-3 fatty acids. Practitioners interpreting DUTCH oestrogen metabolism should also consider the gut microbiome's role in oestrogen recirculation via bacterial beta-glucuronidase activity — an enzyme that cleaves conjugated oestrogens in the intestine, releasing free oestradiol for reabsorption. This gut-oestrogen axis is directly assessable through functional stool testing; the GI-MAP clinician's interpretation guide covers beta-glucuronidase as a reportable marker and the naturopathic interventions for reducing its activity.

The 4-Hydroxylation Pathway (CYP1B1)

4-hydroxyoestrone (4-OH-E1) is considered the most problematic oestrogen metabolite. It is a catechol oestrogen capable of forming semiquinone and quinone intermediates that generate reactive oxygen species and create DNA adducts. Upregulation of CYP1B1 (by dioxins, cigarette smoke, and certain medications) or impaired COMT methylation increases the proportion of 4-OH-E1 relative to its methylated form (4-methoxyoestrone). On the DUTCH report, an elevated 4-OH-E1 in the context of low methylation markers warrants clinical attention and targeted intervention.

The 16-Hydroxylation Pathway (CYP3A4)

16-alpha-hydroxyoestrone (16-OH-E1) is a potent oestrogenic metabolite that binds covalently to oestrogen receptors, producing prolonged oestrogenic stimulation. Elevated 16-OH-E1 is associated with higher body fat percentage (adipose tissue upregulates CYP3A4), alcohol consumption, and hypothyroidism. High 16-OH-E1 relative to 2-OH-E1 is a traditional flag for suboptimal oestrogen detoxification, though the 2:16 ratio has been partially superseded by attention to the 4-OH pathway.

The 2-OH:16-OH Ratio in Practice

The 2-OH:16-OH ratio was popularised as a clinical screening marker. A ratio above 2.0 is generally considered favourable; below 1.0 warrants intervention. However, modern interpretation also requires inspection of the 4-OH-E1 absolute value and the methylation efficiency markers (2-OH-E1:2-methoxyoestrone ratio) before drawing clinical conclusions. The DUTCH report provides all of these values on a single page, enabling integrated pattern recognition rather than isolated ratio assessment.

The Cortisol Curve: Free Cortisol, Total Metabolites, and the CAR

Adrenal function assessment is a cornerstone of integrative practice, and the DUTCH cortisol output is the most comprehensive available outside of 24-hour urinary free cortisol with hospitalised testing.

Free Cortisol Diurnal Pattern

The DUTCH plots free cortisol across the collection time points, producing a visual diurnal curve. A healthy pattern shows high cortisol on waking, peaking in the morning, then steadily declining to low levels by evening and bedtime. Flattened curves (chronically low morning/high evening or uniformly blunted output) correlate with patterns seen in chronic stress, burnout, sleep dysregulation, and HPA axis dysregulation often loosely termed "adrenal fatigue" in functional medicine contexts.

Cortisol Awakening Response (CAR)

The CAR is captured by two timed morning samples: one immediately on waking (within 1 minute) and one exactly 30 minutes later. In a healthy CAR, cortisol rises 50–160% over the 30-minute window. A robust CAR reflects a responsive HPA axis and is associated with effective immune activation, cognitive readiness, and metabolic preparation for the day.

A blunted or absent CAR is consistently associated with burnout, post-viral fatigue, PTSD, and chronic sleep deprivation. An exaggerated CAR can indicate hypervigilance, anticipatory anxiety, or early-stage chronic stress. The CAR cannot be assessed on saliva panels unless explicitly timed in this way, and is entirely invisible on serum testing. For practitioners seeking botanical support for HPA axis dysregulation identified on DUTCH testing, ashwagandha's clinical evidence for cortisol reduction provides a well-replicated option to consider alongside dietary and lifestyle intervention.

Total Cortisol Metabolites: The Adrenal Output Story

Perhaps the most underutilised DUTCH output is total cortisol metabolites (THF + allo-THF + THE). This aggregate represents total hepatic cortisol clearance and, by extension, total adrenal production over the measurement period.

A patient with low free cortisol but high total cortisol metabolites is not adrenally insufficient — they are a fast cortisol metaboliser. Identifying this pattern prevents inappropriate use of adrenal support protocols and instead directs clinical attention to the hepatic enzyme activity (5-alpha and 5-beta reductase) driving rapid clearance. Conversely, low total metabolites with low free cortisol confirms genuinely reduced adrenal output, appropriate for targeted HPA support. For practitioners exploring HPA axis and hormonal peptide research, the DUTCH's metabolite layer provides a necessary baseline before any interventional work.

Cortisone as a Cortisol Activity Surrogate

Cortisone, the inactive form of cortisol, is also measured at each time point. The cortisol:cortisone ratio at each collection reflects 11-beta-HSD2 enzyme activity — the enzyme that inactivates cortisol in tissues like the kidney and gut. Chronically elevated cortisone relative to cortisol can point to excessive cortisol inactivation, which may partially explain tissue-level cortisol insufficiency even when adrenal production appears adequate.

Melatonin and Neurological Markers on the DUTCH

Melatonin (6-OHMS)

The overnight melatonin metabolite 6-sulphatoxymelatonin (6-OHMS) is measured from the first morning urine, capturing the integrated nocturnal melatonin output. This is clinically superior to spot saliva melatonin because it reflects the entire night's secretion rather than a single mid-night time point.

Low 6-OHMS is associated with light-at-night exposure (particularly blue light), shift work, advancing age, beta-blocker use, and inadequate serotonin substrate. In the context of sleep complaints, mood disorders, and immune dysregulation, the melatonin marker adds direct clinical utility. Elevated 6-OHMS, while rarer, may be seen with exogenous melatonin supplementation or in some individuals with delayed sleep phase.

Neurotransmitter Metabolites

The DUTCH includes urinary homovanillate (HVA) and vanilmandelate (VMA), the primary metabolites of dopamine and the catecholamines noradrenaline and adrenaline respectively. While urinary neurotransmitter testing has limitations — peripheral synthesis confounds central nervous system activity assessment — gross abnormalities (very low or very high catecholamine metabolites) can inform clinical patterns and direct further investigation.

Oxidative Stress (8-OHdG)

8-hydroxy-2'-deoxyguanosine (8-OHdG) is a DNA oxidation marker excreted in urine when oxidative damage to cellular DNA occurs. It provides a functional index of systemic oxidative burden relevant to mitochondrial health, inflammageing, and micronutrient adequacy. Naturopaths working in adrenal or metabolic contexts — where mitochondrial energy demands intersect with nutrient depletion — can use this marker alongside the NAD pathway markers to contextualise antioxidant support strategies. For more on the mitochondrial energy substrate landscape, see our article on NAD, NMN, and NR in ageing. Elevated 8-OHdG in the context of chronic cortisol burden also intersects with mTOR-driven suppression of cellular autophagy — the naturopathic framework for autophagy, fasting, and longevity covers how chronic cortisol and insulin elevation keep mTOR active and autophagic flux suppressed, a relevant consideration when addressing oxidative DNA damage identified on DUTCH testing.

Clinical Applications: PCOS, Menopause, Adrenal Dysregulation, and HRT Monitoring

Polycystic Ovary Syndrome (PCOS)

In PCOS, the DUTCH adds significant detail beyond standard serum androgens. Measurement of 5-alpha reductase enzyme activity (via the androsterone:etiocholanolone ratio) reveals whether elevated androgens are being preferentially converted to potent 5-alpha DHT — a finding that directs intervention toward saw palmetto, zinc, and 5-alpha reductase modulation rather than general androgen-lowering strategies. Insulin-driven androgen excess can also be inferred when DHEA-S is elevated alongside elevated testosterone metabolites, prompting metabolic workup.

Perimenopause and Menopause

The DUTCH is well-suited to the perimenopausal transition, when oestrogen fluctuations are greatest and metabolite patterns most clinically significant. Practitioners can assess whether declining oestrogen production is accompanied by favourable or unfavourable metabolite ratios, informing dietary, phytotherapeutic, and if appropriate, HRT decisions. In established menopause, the DUTCH's ability to accurately assess transdermal HRT absorption (serum oestradiol is unreliable with transdermal routes) makes it a preferred monitoring tool for integrative GPs and naturopaths.

Adrenal Dysregulation and Burnout

The multi-layer cortisol output — free cortisol curve, CAR, and total metabolites — provides the most granular non-invasive adrenal assessment available. It distinguishes true adrenal underproduction from fast-clearance patterns, identifies HPA hyperreactivity, and monitors treatment response over time. Combined with the organic acid markers (B6, B12, glutathione, oxidative stress), the DUTCH provides a comprehensive picture of the biochemical terrain underlying fatigue syndromes.

HRT Monitoring

For patients on hormone replacement therapy — whether oestrogen, progesterone, testosterone, or DHEA — the DUTCH provides a monitoring framework unavailable on standard pathology. It confirms delivery and absorption of topical hormones, assesses metabolite shifts post-therapy initiation, and flags concerning pathway elevations (such as rising 4-OH-E1 on an oestrogen protocol) that would not be visible on serum testing alone.

How to Order the DUTCH Test in Australia and Expected Costs

Ordering Pathways in Australia

The DUTCH Complete and DUTCH Plus panels are available in Australia through several authorised distributor channels. Key options include:

Nutripath Integrative Pathology Services — Australia's primary functional pathology provider, offering the DUTCH Complete as a practitioner-orderable test. Practitioners must hold a valid health practitioner registration (AHPRA) or be a Nutripath-approved prescriber.
Precision Analytical Australian portal — Precision Analytical's Australian ordering channel allows practitioners with verified credentials to order directly, with kits shipped domestically.
Integrative GP and naturopath clinics — Many naturopaths and integrative doctors with Nutripath or direct DUTCH accounts can facilitate ordering on behalf of patients.

Collection kits are shipped to the patient's home address. The patient completes timed dried urine collections over a single day (plus two morning collections for the CAR), dries the filter paper, and returns the kit via standard post within 5 days of collection.

Cost in Australia (AUD)

As of 2026, approximate Australian pricing is:

| Panel | Approximate Cost (AUD) | |---|---| | DUTCH Complete | $380–$480 | | DUTCH Plus (with CAR) | $440–$550 | | DUTCH Cycle Mapping | $680–$820 | | DUTCH Sex Hormone Metabolites only | $220–$280 |

Pricing varies by ordering channel, practitioner membership tier, and whether a consultation component is included. Medicare does not rebate DUTCH testing; it is a patient-funded investigation. Some private health funds with health management extras may contribute; patients should check directly with their insurer.

Turnaround time from sample receipt at the laboratory to report delivery is typically 7–15 business days, including any international transit time unless Australian processing is available through the distributor.

How to Interpret DUTCH Results with a Practitioner

The DUTCH report arrives as a multi-page visual output with colour-coded reference ranges, pathway diagrams, and numerical values for each hormone and metabolite. While the report is designed to be visually accessible, accurate clinical interpretation requires training in functional hormone medicine.

Key interpretation principles for practitioners:

Pattern reading over single values. A single elevated or low marker rarely tells the full story. The cortisol metabolite total must be read alongside free cortisol. The 4-OH-E1 value must be read alongside its methylated form. Individual markers in isolation can mislead; patterns across the report reveal the mechanistic story.

Reference ranges are population-derived. DUTCH reference ranges are built from a population of tested individuals rather than from prospective clinical outcome studies. They represent statistical distribution, not necessarily optimal function. Practitioners should integrate DUTCH values with symptom patterns, clinical history, and corroborating pathology.

Retesting timing. When using the DUTCH to monitor treatment response, a minimum of 3 months is generally recommended before retesting to allow adequate time for dietary, supplemental, or prescriptive interventions to shift metabolite patterns. Testing too early produces noise rather than signal.

Hormonal context matters. The DUTCH should be ordered at an appropriate phase of the menstrual cycle (typically days 19–22 for premenopausal women to capture luteal progesterone) or on any day for postmenopausal women or men. Incorrect cycle timing is one of the most common ordering errors and renders the progesterone output uninterpretable.

Correlate with clinical presentation. DUTCH results are a tool, not a diagnosis. Elevated 4-OH-E1 does not diagnose any specific condition; it flags a metabolic pattern warranting clinical attention and supports a targeted intervention strategy. Results must always be interpreted within the full clinical picture by a qualified practitioner.

Practitioner FAQ: DUTCH Test Hormone Testing

1. Can patients order the DUTCH test directly without a practitioner?

In Australia, the DUTCH is primarily a practitioner-ordered test. Some international direct-to-consumer platforms ship kits to Australia, but ordering without a qualified practitioner means the results have no supervised interpretation pathway. Most authorised Australian distributors require a verified practitioner login to place orders. Patients seeking the test are best advised to engage a naturopath, integrative GP, or functional medicine practitioner who can contextualise findings within their clinical presentation.

2. Is the DUTCH test accurate for patients on oral contraceptives or HRT?

The DUTCH can be run on patients using hormonal contraception or HRT, but findings must be interpreted accordingly. Oral contraceptive pill (OCP) users typically show suppressed endogenous oestrogen and progesterone, with elevated synthetic progestin metabolites where detectable. The test is often most useful in this population for assessing cortisol patterns, oestrogen metabolism efficiency, and organic acid markers rather than native sex hormone output. Precision Analytical provides guidance on interpreting results in the context of specific HRT regimens.

3. How does the DUTCH test differ from a standard 24-hour urinary free cortisol test?

A 24-hour urinary free cortisol (UFC) measures only unbound cortisol in a single pooled sample and is primarily a screening tool for Cushing's syndrome and Addison's disease. The DUTCH provides timed (not pooled) free cortisol across four to five time points, adds the CAR, separates free cortisol from total cortisol metabolites, and includes cortisone — giving a functionally richer picture. The 24-hour UFC also collapses the entire day into one value, erasing diurnal information. For functional assessment of HPA axis regulation, the DUTCH is substantially more informative.

4. What should practitioners do if the DUTCH shows elevated 4-OH oestrone?

Elevated 4-OH-E1 warrants a multi-pronged approach. First, assess the methylation efficiency marker (4-OH-E1 to 4-methoxyoestrone ratio) — if methylation is adequate, the risk profile of the elevated 4-OH is partially mitigated. Second, review CYP1B1 inducers: cigarette smoke exposure, dioxin or xenoestrogen burden, and chronic inflammation can all upregulate this pathway. Third, consider COMT support (magnesium, SAMe, riboflavin) if the methylation ratio is unfavourable. Fourth, assess glutathione status via the DUTCH pyroglutamate marker and consider glutathione-precursor support. Referral to an integrative GP for further risk stratification may be appropriate in high-risk presentations.

5. How often should the DUTCH Complete be repeated?

For monitoring treatment response, retesting at 3–6 months post-intervention is standard. For annual health screening in symptomatic patients with hormonal complaints, yearly testing captures longitudinal trends. The DUTCH is not indicated as a quarterly test without specific clinical justification, as hormonal metabolite patterns shift slowly and frequent testing adds cost without proportionate clinical value.

Article prepared for naturopathicscience.org. For practitioner-level education on functional hormone testing, integrative diagnostics, and evidence-based naturopathic protocols, explore the full practitioner library.